Blood Test Could Guide Use of Anti-Inflammatory Drug Celecoxib to Reduce Risk of Colon Cancer Recurrence
Dana-Farber Investigators Pinpoint Keys to Cell Therapy Response for Leukemia
Dana-Farber and Gustave Roussy Announce 2025 Transatlantic Exchange Scientific Program to Focus on Radioligand Therapy
Study Finds Care After Donor Stem Cell Transplant Can Be Safely Shared Between Transplant Centers and Local Oncologists
New Research Shows Inherited Genetic Variants Increase Risk of Certain Pediatric Cancers
Baptist Health Researchers Receive Eight Pilot Project Grants
Turning Up the Heat: Dana-Farber Scientists Describe Key Molecular Shift in Brown Fat Cells
Meet Baptist Health's 'Brains Behind the Brain'
Why Zip Code Matters: How Environment Shapes Cancer Risk
Governor Hochul Celebrates Opening of New York’s First Cell and Gene Therapy Hub at Roswell Park Comprehensive Cancer Center In Buffalo
A Vision for Health Equity in Childhood Cancer
We All Rise Together: Dr. Camille Ragin's Vision for Health Equity in Cancer Care
Early Detection and Interception Research Shows Promise at ASH
First Clinical Trial of “Memory Like” Natural Killer Cells in Ovarian Cancer Opens at Dana-Farber
Building in Access from the Start: Five Efforts by the Centers for Early Detection and Interception
Showing 76 - 90 of 1043 results
Previous| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ...70 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
